Misplaced Pages

Xanthinol: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 23:18, 24 August 2010 edit96.227.210.71 (talk)No edit summary← Previous edit Revision as of 20:57, 18 April 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (Next edit →
Line 1: Line 1:
{{Drugbox {{Drugbox
| verifiedrevid = 380810980
| IUPAC_name = 7--1,3-dimethylpurine-2,6-dione | IUPAC_name = 7--1,3-dimethylpurine-2,6-dione
| image = Xanthinol.png | image = Xanthinol.png

Revision as of 20:57, 18 April 2011

Pharmaceutical compound
Xanthinol
Clinical data
ATC code
  • none
Identifiers
IUPAC name
  • 7--1,3-dimethylpurine-2,6-dione
CAS Number
PubChem CID
DrugBank
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H21N5O4
Molar mass311.33 g/mol g·mol
  (verify)

Xanthinol is a drug prepared from theophylline used as a vasodilator. It is most often used as the salt with niacin (nicotinic acid), known as xantinol nicotinate.

References

  1. 3-(Theophyllyl-7)-1-(N-methyl-N-hydroxyethyl)amino-2-propanol. Yokoyama, Matatsugu; Kawano, Shigeharu. (1963) Japanese Patent 38020588
  2. Xanthinol niacinate at cancerweb.ncl.ac.uk


Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: